Last reviewed · How we verify

NCT05230602

Consuming of Opuntia Among Women With Fibromyalgia

Status unknown NA Last updated 14 December 2022
What this trial tests

NA trial testing opuntia (tzabar fruit) in Fibromyalgia (FM) in 19 participants. Status unknown.

Timeline
1 June 2022
Primary endpoint
1 June 2024
1 June 2024

Quick facts

Lead sponsorSoroka University Medical Center
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposetreatment
Enrollment19
Start date1 June 2022
Primary completion1 June 2024
Estimated completion1 June 2024
Sites1 location across Israel

Drugs / interventions tested

Conditions studied

Sponsor

Soroka University Medical Center

Who can join

Adults 18 to 120, female only, with Fibromyalgia (FM). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To examine whether the addition of tzabar fruit twice a day to a routine daily nutrition regime will: A- Reduce symptoms of fatigue, pain and depression in FM patients B. Have positive influence on quality of life

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Fibromyalgia (FM)

Currently open trials in the same condition.

Other Soroka University Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05230602.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing